Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to Outcomes.
Journal: Anticancer research
Published: January 24, 2026
Better pancreatic adenocarcinoma outcomes linked to anti-EBV TCR CDR3 detection via tumor RNAseq files.
Journal: Human immunology
Published: September 18, 2025
Higher chemical complementarity of EBV epitopes and IGH CDR3s correlates with better outcomes for lymphoma and ovarian cancer.
Journal: Cancer causes & control : CCC
Published: July 10, 2025
Reduced immunogenicity of MYC amplified, metastatic prostate cancer.
Journal: Oncoscience
Published: April 08, 2025
Association of the HLA-DQB1*02 allele with lower tauopathy in Alzheimer's disease.
Journal: Archives of gerontology and geriatrics
Published: December 18, 2024
Survival Distinctions for Cases Representing Immunologically Cold Tumors via Intrinsic Disorder Assessments for Blood-Sourced TRB Variable Regions.
Journal: International journal of molecular sciences
Published: September 24, 2024
Better Outcomes for Ovarian Cancer Associated With the Detection of Anti-EBV TCR CDR3s: Potential Relevance to Diffuse Large B-Cell Lymphoma.
Journal: American journal of reproductive immunology (New York, N.Y. : 1989)
Published: July 29, 2024
Rituximab-Associated Liver Toxicity Without Known Viral Reactivation.
Journal: Cureus
Published: July 09, 2024
Detection of anti-EBV TCR CDR3s associated with better outcomes for EBV-positive, Ugandan cases of Burkitt lymphoma.
Journal: International journal of cancer
Published: June 25, 2024
Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor Timelapse.
Journal: Clinical colorectal cancer
Published: June 10, 2024
High Level Immunoglobulin Gene Expression and Reduced Intra-tumoral Bacteria Associated With the Transition from Initial to Progressive Diffuse Intrinsic Pontine Glioma.
Journal: Anticancer research
Published: March 05, 2024
TCR CDR3-CMV Antigen Chemical Complementaries Are Associated With a Worse Outcome for Renal Cell Carcinoma.
Journal: Anticancer research
Published: December 22, 2023
Last Updated: 09/26/2026